OPTION AND LICENSE AGREEMENT BY AND BETWEEN DERMIRA, INC. AND ALMIRALL, S.A. DATE: FEBRUARY 11, 2019Option and License Agreement • May 7th, 2019 • Dermira, Inc. • Pharmaceutical preparations
This Option and License Agreement (the “Agreement”) is made effective as of February 11, 2019 (the “Effective Date”) by and between Dermira, Inc. a company established under the laws of Delaware, having its principal place of business at 275 Middlefield Road, Suite 150, Menlo Park, CA 94025 (“Dermira”) and Almirall, S.A., a company established under the laws of Spain, having its principal place of business at Ronda General Mitre, 151, 08022 Barcelona – Spain (“Almirall”). Dermira and Almirall are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
ContractFirst Amendment to License Agreement • May 7th, 2019 • Dermira, Inc. • Pharmaceutical preparations
[*****] Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. Redacted information is indicated by brackets.
